Bridgefront Capital »

Summit Therapeutics shares owned by Bridgefront Capital

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Bridgefront Capital from 13F filings

Historical chart of Bridgefront Capital investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Bridgefront Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Bridgefront Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $880k 60k 14.57

More positions owned by Bridgefront Capital

Colgate-Palmolive Company (CL)
Kimberly-Clark Corporation (KMB)
Tyson Foods Cl A (TSN)
Constellation Brands Cl A (STZ)
Lauder Estee Cos Cl A (EL)
Coca-Cola Company (KO)
Molson Coors Beverage CL B (TAP)
American Tower Reit (AMT)
Agree Realty Corporation (ADC)
Wells Fargo & Company (WFC)
Trane Technologies SHS (TT)
Occidental Petroleum Corporation (OXY)
Halliburton Company (HAL)
Citigroup Com New (C)
Spectrum Brands Holding (SPB)

View all positions for Bridgefront Capital

Top funds holding Summit Therapeutics

Baker Bros. Advisors
FMR
BlackRock
T. Rowe Price Associates
State Street Corporation
Vanguard Capital Management
UBS Group
Vanguard Portfolio Management
Goldman Sachs Group
Point72 Asset Management
Geode Capital Management
Citadel Advisors
Susquehanna International
Millennium Management
Adage Capital Partners GP

View all funds holding Summit Therapeutics